TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive “Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases September 18, 1981
TCL Archive Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected October 1, 1976